Internal Medicine, Pulmonary Disease · Morristown, TN
NPI
1205814605
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
500 McFarland St, Suite B
Morristown, TN, 37814
Phone (423) 587-0740
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
3,927 services
Medicare patients, 2024
749
Average age 74
Drug cost, 2024
$6.5M
13,017 prescriptions
Company payments, 2025
$3,417
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernesto Mejia was code 99213 (office e&m - established), 925 times for 531 patients. In total Ernesto Mejia billed 3,927 services in 37 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 925 | 531 | $55.83 | $52K |
| 99231 Hospital E&M - Subsequent | Facility | 759 | 157 | $34.13 | $26K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 284 | 58 | $0.32 | $92.02 |
| 96372 Injection Administration | Office | 237 | 123 | $9.05 | $2,145 |
| 94727 Pulmonary Function Testing | Office | 221 | 220 | $27.90 | $6,165 |
| 94729 Pulmonary Function Testing | Office | 220 | 219 | $35.77 | $7,869 |
| 99222 Hospital E&M - Initial | Facility | 219 | 176 | $88.26 | $19K |
| 99406 Behavioral Health Services | Office | 168 | 107 | $12.99 | $2,182 |
| 94060 Pulmonary Function Testing | Office | 161 | 161 | $23.71 | $3,817 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 146 | 112 | $0.08 | $11.76 |
| 99203 Office E&M - New | Office | 96 | 96 | $68.21 | $6,548 |
| 32554 Other Organ Systems | Facility | 70 | 30 | $59.89 | $4,192 |
| 94010 Pulmonary Function Testing | Office | 59 | 59 | $17.11 | $1,009 |
| 94060 Pulmonary Function Testing | Facility | 54 | 54 | $6.79 | $366 |
| G0008 Administration of influenza virus vaccine | Office | 46 | 46 | $29.78 | $1,370 |
By year: 2022 $177K for 4,563 services; 2023 $177K for 4,597 services; 2024 $146K for 3,927 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ernesto Mejia prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 2,514 prescriptions and refills. In total Ernesto Mejia wrote 13,017 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,514 | 2,918 | 805 | $66K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 2,304 | 2,853 | 529 | $1.8M |
| Prednisone Generic | 1,480 | 1,621 | 707 | $4,137 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 784 | 937 | 205 | $590K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 481 | 564 | 95 | $267K |
| Spiriva Respimat Tiotropium Bromide | 467 | 571 | 121 | $296K |
| Symbicort Budesonide/Formoterol Fumarate | 461 | 620 | 103 | $142K |
| Cefdinir Generic | 372 | 372 | 263 | $4,011 |
| Montelukast Sodium Generic | 322 | 717 | 88 | $3,158 |
| Azithromycin Generic | 319 | 320 | 215 | $3,014 |
| Breo Ellipta Fluticasone/Vilanterol | 270 | 308 | 50 | $122K |
| Ventolin Hfa Albuterol Sulfate | 222 | 245 | 84 | $14K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 178 | 203 | 31 | $91K |
| Fluticasone Propionate Generic | 158 | 274 | 54 | $1,904 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 154 | 210 | 29 | $101K |
Brand drugs: 7,818 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernesto Mejia $3,417 ($3,417 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $932.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 32 | $932 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $318 |
| GlaxoSmithKline, LLC. GSK | 26 | $312 |
| Verona Pharma, Inc. VRNA | 17 | $248 |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $227 |
| Amgen Inc. AMGN | 14 | $216 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $195 |
| Insmed, Inc. INSM | 9 | $186 |
| Genzyme Corporation SNY | 10 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.